Kissick Family Foundation Frontotemporal Dementia Grant Program (2026–2027) supports researchers studying sporadic FTD through basic and early translational science to advance understanding, diagnosis, and treatment.
Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
The Treat FTD Fund from the Alzheimer's Drug Discovery Foundation supports early-stage research and clinical trials to develop new therapies and biomarkers for frontotemporal degeneration.
Accelerating Drug Discovery for FTD supports investigators developing small molecule and biologic drugs through lead optimization and animal-model testing to advance disease-modifying treatments for FTD.
The Treat FTD Fund supports early-stage clinical trials for innovative FTD treatments, prioritizing biomarker integration and novel trial designs, funded by The Association for Frontotemporal Degeneration.
The Clinical Research Award in Frontotemporal Degeneration funds early career investigators conducting clinical research to advance understanding and care in FTD, supported by the American Academy of Neurology.